NEURONES: 3.9% increase in organic growth in the 1st quarter of 2025

07.05.25 17:40 Uhr

Werte in diesem Artikel
Aktien

48,65 EUR 0,80 EUR 1,67%

PRESS INFORMATION
Heading: 1st quarter revenues 2025        Nanterre, May 7, 2025 (after trading)

Wer­bung

3.9% increase in organic growth in the 1st quarter of 2025

(in millions of euros)Q1 2024Q1 2025Growthof which organic
Revenues204.9214.1+ 4.5%+ 3.9%

Achievements

Driven by its cloud, digital and data activities, the Group's organic growth increased by 3.9% over the first three months of the year.

Wer­bung

Operating profit (*) totaled 8.2% of revenues. The increase in taxation (the fixed social security charge on bonus shares rose from 20% to 30%) represented an expense of one million euros, entirely entered into the books at the start of the year (i.e. 0.5% of 1st quarter revenues).

Compared to the 2024 Universal Registration Document (www.neurones.net - Investors), the financial position has not changed significantly.

Outlook

Taking into account limited visibility, NEURONES' forecasts for the full financial year 2025 are as follows:

Wer­bung

  • revenues between €840 and €850 million,
  • operating profit between 8.5% and 9% of revenues.

These forecasts may be adjusted when the Group publishes its revenues for the first half of the year.

(*) not audited and after inclusion of 1.2% of expenses related to bonus shares.

About NEURONES
With 7,250 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations make their transition to a digital and sustainable economy, implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) – Euronext Tech Leaders – DSS mid-caps – PEA-PME eligible
www.neurones.net

Press Relations:
O'Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03

jpbrutin@oconnection.fr


NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
rp@neurones.net
Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
investisseurs@neurones.net

Attachment


Ausgewählte Hebelprodukte auf NeuronesAct.

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf NeuronesAct.

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu NeuronesAct.

Wer­bung